Vaccine composition for controlling ectoparasite infestations
    2.
    发明授权
    Vaccine composition for controlling ectoparasite infestations 有权
    用于控制外寄生虫感染的疫苗组合物

    公开(公告)号:US09085634B2

    公开(公告)日:2015-07-21

    申请号:US13825892

    申请日:2011-09-26

    摘要: The present invention relates to the use of a peptide of P0 ribosomal protein in the manufacture of a vaccine composition to control of ectoparasite infestations and therefore the transmission of their associated pathogens. This peptide is located between 267 and 301 amino acids of the P0 protein, and can be obtained by recombinant means or by chemical synthesis. This peptide can be fused to a carrier protein or peptide, or an immuno-carrier and be included in an oily formulation. The formulations comprising the peptide vaccine confer protection against ticks and ectoparasites known as “sea lice” without generating autoimmunity in the host organism. Among these ticks may be mentioned species as Rhipicephalus microplus, Rhipicephalus sanguineus and Ixodes scapularis, and between sea lice are those of the Caligus and Lepeophtheirus genera.

    摘要翻译: 本发明涉及P0核糖体蛋白的肽在制造疫苗组合物中用于控制外寄生虫感染和因此传播其相关病原体的用途。 该肽位于P0蛋白的267和301个氨基酸之间,可以通过重组方法或通过化学合成获得。 该肽可以与载体蛋白或肽或免疫载体融合并包含在油性制剂中。 包含肽疫苗的制剂赋予对称为“海虱”的蜱和外寄生物的保护,而不在宿主生物体中产生自身免疫。 在这些蜱中,可以列举物种如红R属(Rhipicephalus microplus),R,属(Rhipicephalus sanguineus)和sc and属(Ixodes scopularis),海虱属Caligus和Lepeophtheirus属。

    VACCINE COMPOSITION FOR CONTROLLING ECTOPARASITE INFESTATIONS
    3.
    发明申请
    VACCINE COMPOSITION FOR CONTROLLING ECTOPARASITE INFESTATIONS 有权
    用于控制ECTOPARASITE INFESTATIONS的疫苗组合物

    公开(公告)号:US20130273095A1

    公开(公告)日:2013-10-17

    申请号:US13825892

    申请日:2011-09-26

    IPC分类号: C07K14/435 A61K39/00

    摘要: The present invention relates to the use of a peptide of P0 ribosomal protein in the manufacture of a vaccine composition to control of ectoparasite infestations and therefore the transmission of their associated pathogens. This peptide is located between 267 and 301 amino acids of the P0 protein, and can be obtained by recombinant means or by chemical synthesis. This peptide can be fused to a carrier protein or peptide, or an immuno-carrier and be included in an oily formulation. The formulations comprising the peptide vaccine confer protection against ticks and ectoparasites known as “sea lice” without generating autoimmunity in the host organism. Among these ticks may be mentioned species as Rhipicephalus microplus, Rhipicephalus sanguineus and Ixodes scapularis, and between sea lice are those of the Caligus and Lepeophtheirus genera.

    摘要翻译: 本发明涉及P0核糖体蛋白的肽在制造疫苗组合物中用于控制外寄生虫感染和因此传播其相关病原体的用途。 该肽位于P0蛋白的267和301个氨基酸之间,可以通过重组方法或通过化学合成获得。 该肽可以与载体蛋白或肽或免疫载体融合并包含在油性制剂中。 包含肽疫苗的制剂赋予对称为“海虱”的蜱和外寄生物的保护,而不在宿主生物体中产生自身免疫。 在这些蜱中,可以列举物种如红R属(Rhipicephalus microplus),R,属(Rhipicephalus sanguineus)和sc and属(Ixodes scopularis),海虱属Caligus和Lepeophtheirus属。